Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1096 Articles

Chris Lange | Jan 20, 2015 at 8:30 AM EST

Johnson & Johnson Barely Pulls Through on Strong Pharma Sales

Johnson & Johnson reported better than expected fourth-quarter results Tuesday before the market open.

Paul Ausick | Jan 15, 2015 at 4:01 PM EST

The 4 Stocks That Sank Thursday’s Market

thinkstockJanuary 15, 2015: Markets opened higher on Thursday following an announcement from the Swiss National Bank that it would no…

Jon C. Ogg | Jan 15, 2015 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Apple, Barrick Gold, Corning, Groupon, Peabody, SolarCity and More

Thursday's top analyst upgrades, downgrades include Apple, Barrick Gold, Corning, Groupon, Peabody Energy and SolarCity.

Lee Jackson | Jan 12, 2015 at 8:50 AM EST

Analyst’s Top Stock Picks for 2015 That Are Unloved by Wall Street

Cowen has a long list of stocks that are out of favor at many other firms on Wall Street. These…

Jon C. Ogg | Jan 8, 2015 at 8:15 AM EST

The Bullish and Bearish Case for Johnson & Johnson in 2015

One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have…

Paul Ausick | Nov 18, 2014 at 9:10 AM EST

Companies Spending the Most on R&D

For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.

Jon C. Ogg | Nov 14, 2014 at 4:58 PM EST

Significant Changes in Buffett and Berkshire Hathaway Holdings

courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s…

Chris Lange | Nov 14, 2014 at 11:35 AM EST

What Licensing Imetelstat Will Mean for Geron

Geron hasannounced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize…

Paul Ausick | Nov 4, 2014 at 4:01 PM EST

The 4 DJIA Stocks Leading the Market to a Mixed Close

thinkstockNovember 4, 2014: Markets opened slightly lower on Tuesday as the bottom fell out on crude oil which went on…

Paul Ausick | Oct 14, 2014 at 4:01 PM EDT

The 4 DJIA Stocks That Kept the Index Flat

thinkstockOctober 14, 2014: Markets opened higher on Tuesday and had put up a nice gain by noon. Then the wheels…

Paul Ausick | Oct 14, 2014 at 9:05 AM EDT

Drug Sales Energize Johnson & Johnson Earnings

Johnson & Johnson reported better-than-expected third-quarter 2014 results before markets opened Tuesday.

Jon C. Ogg | Oct 10, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: EMC, IBM, Procera Networks, Wayfair, Yelp and More

These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Friday, October 10, 2014.

Paul Ausick | Oct 7, 2014 at 4:01 PM EDT

The 4 Stocks That Tanked the Market

thinkstockOctober 7, 2014: Markets opened lower on Tuesday and never even took a serious run at the break-even line. The…

Lee Jackson | Oct 2, 2014 at 8:55 AM EDT

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.

Jon C. Ogg | Sep 29, 2014 at 4:05 PM EDT

The Best- and Worst-Performing DJIA Stocks in 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

1 … 38 39 40 41 42 … 74

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Johnson & Johnson Barely Pulls Through on Strong Pharma Sales

The 4 Stocks That Sank Thursday’s Market

Top Analyst Upgrades and Downgrades: Apple, Barrick Gold, Corning, Groupon, Peabody, SolarCity and More

Analyst’s Top Stock Picks for 2015 That Are Unloved by Wall Street

The Bullish and Bearish Case for Johnson & Johnson in 2015

Companies Spending the Most on R&D

Significant Changes in Buffett and Berkshire Hathaway Holdings

What Licensing Imetelstat Will Mean for Geron

The 4 DJIA Stocks Leading the Market to a Mixed Close

The 4 DJIA Stocks That Kept the Index Flat

Drug Sales Energize Johnson & Johnson Earnings

Top Analyst Upgrades and Downgrades: EMC, IBM, Procera Networks, Wayfair, Yelp and More

The 4 Stocks That Tanked the Market

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The Best- and Worst-Performing DJIA Stocks in 2014

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

BofA Just Deemed Ulta Beauty a High-Quality Compounder. Time to Buy the 26% Pullback?

The One Life-Changing Stock I Can’t Stop Buying

Warren Buffett’s 3 Best Bargains Under $30

The IRA and 401(K) Tax Trap That Catches Retirees off Guard

Is College Still Worth It? Ron Lieber's Advice for Parents Navigating Shifting Job Market

Oil’s Decline Opens the Door on These 4 Sub-$30 Buys

BofA Just Deemed Ulta Beauty a High-Quality Compounder. Time to Buy the 26% Pullback?

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Johnson & Johnson Barely Pulls Through on Strong Pharma Sales

The 4 Stocks That Sank Thursday’s Market

Top Analyst Upgrades and Downgrades: Apple, Barrick Gold, Corning, Groupon, Peabody, SolarCity and More

Analyst’s Top Stock Picks for 2015 That Are Unloved by Wall Street

The Bullish and Bearish Case for Johnson & Johnson in 2015

Companies Spending the Most on R&D

Significant Changes in Buffett and Berkshire Hathaway Holdings

What Licensing Imetelstat Will Mean for Geron

The 4 DJIA Stocks Leading the Market to a Mixed Close

The 4 DJIA Stocks That Kept the Index Flat

Drug Sales Energize Johnson & Johnson Earnings

Top Analyst Upgrades and Downgrades: EMC, IBM, Procera Networks, Wayfair, Yelp and More

The 4 Stocks That Tanked the Market

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The Best- and Worst-Performing DJIA Stocks in 2014

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

BofA Just Deemed Ulta Beauty a High-Quality Compounder. Time to Buy the 26% Pullback?

The One Life-Changing Stock I Can’t Stop Buying

Warren Buffett’s 3 Best Bargains Under $30

Featured Reads

The IRA and 401(K) Tax Trap That Catches Retirees off Guard

Is College Still Worth It? Ron Lieber's Advice for Parents Navigating Shifting Job Market